# Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma

> **NCT01122680** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 105 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Tiotropium bromide
- **DRUG:** tiotropium bromide
- **DRUG:** tiotropium bromide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01122680
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-04
- **Final completion:** —
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2014-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01122680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01122680, "Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT01122680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*